McKesson Corporation (ticker: MCK, exchange: New York Stock Exchange (.N))
News Release -
McKessonHBOC Selects Five Employees to Lead Post-Merger Initiatives for Product Pull-Through and Development
SAN FRANCISCO--(BW HealthWire)--Feb. 22, 1999--McKesson HBOC,
Inc., (NYSE:MCK) (McKessonHBOC) announced today that it has selected
five employees for a dedicated cross-functional Affiliation Team that
will spearhead the execution of strategic initiatives for product
pull-through and development of products and services across
This two-year effort to capture additional value from the
McKessonHBOC merger has a goal to deliver $200 million in pre-tax
income through revenue and expense synergies achieved by pull-through
of existing products to current customers and cost-savings through
efficiencies, better facilities utilization, standardization of
practices and contract leverage.
Also, team members will lead efforts to integrate products, to
broaden and enhance existing capabilities, take to market integrated
product solutions and launch McKessonHBOC's capability for new product
The Affiliation Team, led by David A. Schenk, senior vice
president of McKessonHBOC, consists of Monika H. Brown, Rick Hall,
Sandra Schafer, Aldo Zini and Kathy Zirker-Smith.
"Each team member brings extensive knowledge of both the
organization and the needs of McKessonHBOC's customers, and will
together provide a strong base of experience in both supply management
and information technology," said Schenk.
"Each team member has been a high performer throughout his or her
career and thus brings both personal and professional momentum to the
challenge and opportunity we have. Working together over the next two
years, we will lead work groups throughout the company to execute
strategic plans designed to create value for our customers, suppliers,
stockholders and employees and accelerate the company's growth."
Monika Brown joined HBOC in 1985. Before joining the Affiliation
Team, she was director of investor relations for HBOC, with
responsibility for all external financial and strategic communications
with the investment community. Monika's previous responsibilities
included managing HBOC's internal financial planning, including
budgets, forecasts, performance measurements and strategic business
planning. She has a bachelor's degree in business administration and
finance from Ohio State University.
Rick Hall joined McKesson General Medical in 1985 as a district
manager. Since 1997, he has been president, Acute Care, the business
focused on medical-surgical supply management solutions for hospitals
and integrated health networks. He played a key role in negotiating
and then implementing major distribution agreements with VHA and
Previously, Rick worked in pharmaceutical distribution with
McKesson Health Systems. Rick has a bachelor's of science degree in
healthcare administration from Pennsylvania State University and has
served actively on numerous healthcare industry committees and boards.
Sandra Schafer joined HBOC with its acquisition of Amherst
Associates in 1985. Prior to joining the Affiliation Team, Sandra was
vice president of marketing for the physician market. In this
position, she was responsible for positioning and information systems
solutions designed to meet all requirements of physician practices.
Schafer previously held leadership positions in the areas of
business partner development, sales operations and sales support. She
has a bachelor's degree in business administration from the University
of Iowa and a master's degree in hospital and health administration.
Aldo Zini joined McKesson's Automated Healthcare business in 1991
as vice president, sales and marketing. In mid-1997, Zini moved to his
present position as senior vice president of Marketing and Strategic
Business Services for the Health Systems pharmaceutical supply
Prior to joining Automated Healthcare, Zini was executive
director of Technology and Marketing Research for Gerber Alley
Corporation, which is now a part of McKessonHBOC's Information
Technology Business. He also worked in healthcare management
consulting. He has a bachelor's degree in Industrial Engineering from
the University of Pittsburgh and a master's degree in Health Systems
Management from Carnegie-Mellon University.
Kathy Zirker-Smith has been with McKesson's Corporate Planning
Department since 1995, most recently as vice president, Strategic
Planning and Corporate Initiatives. Zirker-Smith has played a key role
in numerous mergers and acquisitions, in post-merger affiliation and
strategy development at McKesson General Medical, and in the design
and launch of the Select Generics program for retail pharmacies.
She came to McKesson from Kaiser Permanente, where she managed
the Strategic Projects Group, and earlier was a consultant at APM, a
healthcare consulting firm. Zirker-Smith has a bachelor's degree in
Mathematics from the University of Texas, a graduate degree in
International Business Policy from the London School of Economics and
an MBA from the University of California, Berkeley.
McKesson HBOC, Inc., a Fortune 100 corporation, is the world's
largest healthcare services company. McKessonHBOC provides
pharmaceutical supply management and information technologies across
the entire continuum of healthcare, including market-leading
businesses in pharmaceutical and medical-surgical distribution,
information technology for healthcare providers, services for payors
and outsourcing. More information about McKessonHBOC is available on
our World Wide Website at: www.mckhboc.com.
Except for the historical information contained herein, the
matters discussed in this press release may constitute forward-looking
statements that involve risks and uncertainties that could cause
actual results to differ materially from those projected. These
statements may be identified by their use of forward-looking
terminology such as "believes," "expects," "may," "should," "intends,"
"plans," "estimates," "anticipates" and similar words. Risks and
uncertainties include the speed of integration of acquired businesses,
the impact of continued competitive pressures, success of strategic
initiatives, implementation of new technologies, continued industry
consolidation, changes in customer mix, changes in pharmaceutical
manufacturers' pricing and distribution policy, the changing U.S.
health care environment and other factors discussed from time to time
in reports filed by McKesson HBOC, Inc. with the Securities and
Exchange Commission. The company assumes no obligation to update
information contained in this release.
McKessonHBOC news releases are available at no charge through
McKessonHBOC's NewsOnDemand fax service. To immediately receive an
index of available releases, call 1-800-344-6495 and press 2.
CONTACT: McKesson HBOC, Inc.,
Larry Kurtz, 415/983-8418 (Media)
Janet Bley, 415/983-9357 (Investors)
Beth Dalton, 770/393-6587 (Investors)
INDUSTRY KEYWORD: MEDICINE PHARMACEUTICAL MANAGEMENT CHANGES